A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study

SIMPLE SUMMARY: In the recent years, immune checkpoint inhibitors (ICIs) have significantly modified non-small cell lung cancer (NSCLC) treatment by providing new therapeutic avenues with superior efficacy and improved tolerability over traditional cytotoxic therapies. The immune activation can lead...

Descripción completa

Detalles Bibliográficos
Autores principales: Yolchuyeva, Sevinj, Giacomazzi, Elena, Tonneau, Marion, Ebrahimpour, Leyla, Lamaze, Fabien C., Orain, Michele, Coulombe, François, Malo, Julie, Belkaid, Wiam, Routy, Bertrand, Joubert, Philippe, Manem, Venkata S. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417039/
https://www.ncbi.nlm.nih.gov/pubmed/37568646
http://dx.doi.org/10.3390/cancers15153829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417039/
https://www.ncbi.nlm.nih.gov/pubmed/37568646
http://dx.doi.org/10.3390/cancers15153829

Ejemplares similares